ICYMI: Watch CZ's E&C Hearing Opening Remarks

On Wednesday, September 20, 2023, CZ was invited to speak in front of the House Energy and Commerce Subcommittee on Oversight and Investigation’s hearing on the impact of the IRA’s price controls on cures for patients. CZ described his journey with Multiple Sclerosis (MS) and how the same innovative drugs keeping him and other patients alive are under direct threat by these baseless “negotiations.” We’re thankful that the committee gave him a chance to speak out on behalf of patients and tell lawmakers that their policies have real consequences for those that need a thriving medical innovation ecosystem to afford them a chance at surviving their illness.

Previous
Previous

SFS Statement on Drug Manufacturers Participating in the IRA’s Medicare Drug Price “Negotiations”

Next
Next

Blog Post: Patients, Be Heard!